Manufacturer record
BRD Medilabs (Unit-II): regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by BRD Medilabs (Unit-II) (Himachal Pradesh) were declared Not of Standard Quality between October 2025 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: BRD240848A, Paracetamol Sustained Release Tablets USP (exp Nov 2027). RDTL, Ernakulam (state lab) found it not of standard quality: Sample does not conform to USP Standards. It fails the test Dissolution as per USP. Listed in the September 2026 alert.
Records by type
2 records linked to BRD Medilabs (Unit-II) in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol Sustained Release Tablets USP | Batch BRD240848AMfg Dec 2024 · Exp Nov 2027 | Sample does not conform to USP Standards. It fails the test Dissolution as per USP.Dissolution | RDTL , ErnakulamState lab | Sep 2026 |
| Atorest 10 (Atorvastatin Tablets IP) | Batch BRD250018Mfg Apr 2025 · Exp Mar 2027 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Oct 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.